Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March... Read more.
insitro Completes First AI-Enabled Human Genetics Study of Brown Adipose Tissue, Shares Differentiated Targets with Anti-Obesity Effects
AI-enabled brown adipose tissue (BAT) phenotype unlocks population-scale human genetic discovery BAT-01 knockdown drives 15% body-weight reduction in preclinical... Read more.
Teradyne Reports Fourth Quarter and Full Year 2025 Results
Revenue and earnings above the high-end of Q4 guidance Revenue of $1.083 billion in Q4’25, up 44% from Q4’24 and up 41% from Q3’25 Q4 growth driven by... Read more.
Heitman and Erben to Develop Western Australia’s Largest PBSA asset in the core of Perth CBD
Perth City Link site will be transformed into a 1,146-bed, 19-storey student accommodation community MELBOURNE, Australia–(BUSINESS WIRE)–Heitman LLC... Read more.
Samsara to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on March 5, 2026
SAN FRANCISCO–(BUSINESS WIRE)–Samsara Inc. (“Samsara”) (NYSE: IOT), the pioneer of the Connected Operations® Platform, today announced it... Read more.
Asana to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on Monday, March 2, 2026
SAN FRANCISCO–(BUSINESS WIRE)–Asana, Inc. (NYSE: ASAN)(LTSE: ASAN), a leading work management platform for human + AI collaboration, announced today... Read more.
Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced... Read more.
Optimum to Hold Conference Call to Discuss Q4 and Full Year 2025 Results
NEW YORK–(BUSINESS WIRE)–Optimum Communications (NYSE: OPTU) will host a conference call on Thursday, February 12, 2026, at 8:30 a.m. ET to discuss financial... Read more.
Janus International Group Successfully Completes Term Loan Repricing
TEMPLE, Ga.–(BUSINESS WIRE)–Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading provider of building product solutions... Read more.
Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union
– Company expects to receive a negative opinion following oral explanation feedback and intends to request re‑examination upon review of formal adoption.... Read more.